HIGH-VOLUME · FEMALE-LED
meloxicam Side Effects
meloxicam (also sold as Mobic) is HIGH-VOLUME in this FAERS book #130 of 524 by FAERS report count. Signature opener: FEMALE-LED - 72% of sex-coded reports are female (36,971 F / 14,619 M).
Data updated 2026-05-15
- 55,835
- FAERS reports
FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
meloxicam reporting skew - 72% of sex-coded reports are female (36,971 F / 14,619 M). Volume band HIGH-VOLUME #130 of 524 by FAERS report count; caseload CASELOAD.
High-report extract for meloxicam (Mobic): 55,835 FAERS rows (2004-2025). Top named reactions: PAIN, FATIGUE, ARTHRALGIA. Outcome stamps DEATH-HEAVY · HOSP-MID · FEMALE-LED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2004–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
PAIN leads 4,670 of 55,835 reports
FEMALE-LED reporters · age peak 45-64
Female-led reporters (72% of sex-coded rows)
Age peak 45-64 (16,457 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,542 reports, 6.3%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 979 |
| COMPLETED SUICIDE | 484 |
| DIARRHOEA | 446 |
| CONFUSIONAL STATE | 423 |
| DYSPNOEA | 421 |
| FATIGUE | 421 |
| ARTHRALGIA | 410 |
| ASTHENIA | 409 |
| VOMITING | 409 |
| MOBILITY DECREASED | 405 |
| MALAISE | 400 |
| TYPE 2 DIABETES MELLITUS | 399 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 396 |
| PAIN | 393 |
| ABDOMINAL PAIN UPPER | 391 |
| DECREASED APPETITE | 391 |
| HYPERTENSION | 391 |
| SYSTEMIC LUPUS ERYTHEMATOSUS | 390 |
| NAUSEA | 387 |
| DUODENAL ULCER PERFORATION | 384 |
Reactions in Hospitalization Reports
Hospitalization mid-share (13,382, 24.0%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| PAIN | 1,376 |
| DYSPNOEA | 1,314 |
| FATIGUE | 1,307 |
| PNEUMONIA | 1,297 |
| ARTHRALGIA | 1,292 |
| NAUSEA | 1,252 |
| DIARRHOEA | 1,144 |
| VOMITING | 1,045 |
| ASTHENIA | 1,022 |
| MALAISE | 994 |
| DIZZINESS | 968 |
| HEADACHE | 946 |
| FALL | 892 |
| PYREXIA | 880 |
| CONDITION AGGRAVATED | 850 |
| HYPERTENSION | 837 |
| RHEUMATOID ARTHRITIS | 825 |
| ANXIETY | 824 |
How to read meloxicam FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-MID)
FAERS holds 55,835 voluntary reports linked to meloxicam (Mobic), 2004-2025. Death is listed on 3,542 (6.3%). Hospitalization appears on 13,382 (24.0%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; FEMALE-LED is the page opener, not a per-patient risk.
Read with meloxicam
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 55,714 FAERS cases (Δ 121 lighter vs meloxicam); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 55,963 FAERS cases (Δ 128 heavier vs meloxicam); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 55,549 FAERS cases (Δ 286 lighter vs meloxicam); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 55,389 FAERS cases (Δ 446 lighter vs meloxicam); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 55.8 pp vs meloxicam's DEATH-HEAVY): CASELOAD · HOSP-MID.
meloxicam stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.